DUX4 and facioscapulohumeral muscular dystrophy: 2′-O-methyl phosphorothioate ASOs targeting the splice sites or the PAS of the DUX4 transcript reduced DUX4 expression, the percentage of DUX4-positive nuclei, and atrophy in FSHD primary myotube cultures.14